Aduro Biotech (Aduro), a Triton launched company formed in 2010, stays at the forefront of discovery, development and commercialization of immunotherapies, alone or in combination; that make transformative advances in the treatment of challenging diseases.
FRX Polymers, Inc.
FRX Polymers, Inc., a (formed by Triton in 2007) manufactures Nofia® polyphosphonates - fire resistant plastics. Nofia products are fully transparent, high flowing and, due to their high phosphorus content, are inherently flame retardant.
Fluence specializes in developing energy-efficient wastewater treatment solutions. The company’s innovative Membrane Aerated Biofilm Reactor (MABR) technology is installed at sites around the world.
Sensera is an integrated, fast turnaround client-specific designer and manufacturer of specialized high performance microsensors and micro-fabricated components for the Healthcare, Industrial, Defense and Aerospace markets.
Featured Incubated Products
A Plug and Play ‘Sensitivity Amplifier’ that enables chemical sensors for threat and contraband detection.
MEMS Sensors & Manufacturing
Sensera designs, engineers and manufactures MEMS-based sensors and other devices for industrial, medical and defense applications.
(Fiber Reinforced Aluminum)
Triton FRA Composites is a fiber reinforced aluminum composite that offers light weight and high strength alternatives to heavy steel for bearing applications.
Triton Systems Company Video
To celebrate Triton's 25 Years in Busines, Triton launched a new video showcasing it's accomplishments, technologists and the vision of the company for the next generation of innovation. To view: https://www.youtube.com/watch?v=rOETFI7EJ3k
Sensera expands microfluidic fabrication capabilities into new medical diagnostic applications
February 19, 2019 -- Sensera. (ASX: SE1) Sensera has expanded its capabilities to include chips for Point-of-Care and Lab-on-a-Chip applications, as well as droplet microfluidic devices. The Company has achieved this expansion of microfluidic product applications in partnership with newly engaged customers.
Fluence unveils SUBRE with announcement of sales
Melbourne, New York March 18, 2019: Fluence Corporation Limited (ASX: FLC) is pleased to announce the commercial launch of its SUBRE submerged membrane aerated biofilm reactor (MABR) solution, available in two configurations: as a retrofit upgrade, and as a new greenfield plant.
Aduro Announces First Patient Dosed in Phase 1 Study of ADU-S100 (MIW815) in Combination with YERVOY
BERKELEY, Calif., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO) today announced that the first patient has been dosed in a Phase 1 trial of ADU-S100 (MIW815), a novel stimulator of interferon genes (STING) pathway activator, in combination with YERVOY® (ipilimumab), an approved anti-CTLA-4 antibody for the treatment of relapsed and refractory melanoma.